Bergman, Ruiz Introduce Bipartisan Bill to Preserve Critical Drug Discounts for Safety Net Providers

In response to proposed changes to the 340B Program by federal regulators and drug manufacturers, Representatives Jack Bergman and Raul Ruiz have introduced the bipartisan Safety Net Provider Drug Pricing Protection Act. This legislation aims to preserve critical drug discounts for safety net providers, which include Critical Access Hospitals and Federally Qualified Health Centers. The proposed changes would replace up-front discounts with a rebate-based model, compelling providers to buy medications at full price and wait for reimbursement. Such a shift poses substantial financial and administrative challenges for smaller safety-net providers, threatening their ability to deliver essential healthcare services.

Rep. Bergman has previously attempted to block the rebate model through his Community Health Center Drug Pricing Protection Act. While the initial implementation of the rebate model was postponed, a revised version is set to begin on January 1, 2027. The new Safety Net Provider Drug Pricing Protection Act broadens protections for various safety net providers, ensuring they are not forced to pay more than the 340B ceiling price at the time of purchase. This measure is crucial for safeguarding financially vulnerable providers, allowing them to allocate resources more effectively toward patient care.

Both Representatives Bergman and Ruiz emphasize the importance of the 340B Program for rural healthcare providers. Bergman argues that many rural hospitals and community health centers operate on very tight budgets, making it imperative to avoid additional financial burdens from Washington mandates. Ruiz echoes this sentiment, stating that safety net providers are essential for serving vulnerable patient populations and cannot afford the upfront costs associated with the proposed rebate model. Both lawmakers are committed to ensuring that the 340B Program remains a viable resource for these healthcare facilities.

Support for the Safety Net Provider Drug Pricing Protection Act extends beyond lawmakers to various healthcare organizations. Leaders from hospitals and healthcare systems, such as Aspirus Health and OSF St. Francis Hospital, express strong support for the bill, highlighting its importance in maintaining access to affordable medications for rural communities. They stress that programs like 340B are vital for managing limited resources and providing necessary treatments, particularly for patients who might otherwise forgo care due to costs.

Overall, the Safety Net Provider Drug Pricing Protection Act represents a critical step in preserving the integrity of the 340B Program. By maintaining up-front discounts, the legislation aims to alleviate the financial and administrative burdens that safety net providers face, ensuring they can continue to serve their communities effectively. The bipartisan support for this initiative underscores the recognition of the essential role that these providers play in delivering healthcare to rural and underserved populations.